The Patent Finder

Sangamo Therapeutics, Inc.

139 patents currently held · Updated Nov 21, 2026
13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Sangamo Biosciences, Inc. (to 2017)

25
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 4 fees due Nov 21 to 30, 2026 · next Nov 21
  • 1 fee due Jan 9, 2027
    The maintenance fee for Engineered Zinc Finger Proteins Targeting 5-Enolpyruvyl SHIKIMATE-3-Phosphate Synthase Genes (US 10,344,289) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
  • 6 fees due Feb 6 to 15, 2027 · next Feb 6
  • 1 fee due Mar 10, 2027
    The maintenance fee for Methods and Compositions for Treating Hemophilia (US 10,407,476) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
  • 8 fees due Apr 6 to 24, 2027 · next Apr 6
  • 3 fees due May 12 to 28, 2027 · next May 12
  • 7 fees due Jun 1 to 22, 2027 · next Jun 1
  • 4 fees due Jul 2 to 21, 2027 · next Jul 2
  • 5 fees due Aug 9 to 23, 2027 · next Aug 9
  • 2 fees due Sep 5 to 30, 2027 · next Sep 5
  • 3 fees due Oct 14 to 26, 2027 · next Oct 14
  • 5 fees due Nov 5 to 14, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 23, 2026
  • 6 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,648,267Methods and Compositions for Gene Inactivation
In force
 · Low confidence
In forceLow confidence
US 10,717,993Methods and compositions for increased transgene expression
In force
 · USPTO record
In forceUSPTO record
US 7,972,854Methods and Compositions for Targeted Cleavage and Recombination
In force
 · High confidence
In forceHigh confidence
US 11,884,930Method of Inactivating a Glucocorticoid Receptor Gene in an Isolated Cell
In force
 · High confidence
In forceHigh confidence
US 7,914,796Engineered Cleavage Half-Domains
In force
 · High confidence
In forceHigh confidence
US 9,045,763Linear donor constructs for targeted integration
In force
 · Medium confidence
In forceMedium confidence
US 9,267,154Targeted Integration into the PPP1R12C Locus
In force
 · High confidence
In forceHigh confidence
US 11,649,468Targeted Integration into the PPP1R12C Locus
In force
 · High confidence
In forceHigh confidence
US 8,110,379Targeted Integration into the PPP1R12C Locus
In force
 · High confidence
In forceHigh confidence
US 9,322,036Methods and Compositions for Inactivating Alpha 1,6 Fucosyltransferase (FUT8) Gene Expression
In force
 · High confidence
In forceHigh confidence
10 of 139 patents shown.
Pro members see all 139.
Pro members: see all 139 patents
Also on record, not counted in the 139: 13 patents in force now held by others · 57 lapsed for an unpaid fee · 20 ended at full term · 2 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

20 pending · 40 abandoned · 10 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited